Intellijoint Surgical

Intellijoint Surgical is a company focused on the development and commercialization of innovative surgical navigation solutions specifically designed for total joint replacements. Their product lineup includes Intellijoint HIP®, which provides real-time, intraoperative implant measurements to enhance the accuracy of hip arthroplasty. Intellijoint KNEE® assists surgeons by offering precise intraoperative measurements for implant positioning during knee arthroplasty procedures. Additionally, Intellijoint VIEW™, a web-based surgical planning tool, facilitates functional cup planning and implant templating without the need for CT imaging, streamlining the preoperative planning process. The company has achieved significant regulatory milestones, securing approvals for Intellijoint HIP® from Health Canada, the FDA, the TGA, and Japan PMDA. Intellijoint KNEE® is similarly endorsed by Health Canada, the FDA, and the TGA, while Intellijoint VIEW™ is licensed in Canada and has received 510(K) clearance from the FDA. In a strategic move to focus on profitable growth, Intellijoint Surgical announced a workforce reduction in October 2023. Furthermore, the company expanded its market presence in Japan with a second product approval for Intellijoint KNEE® in March 2024.